O. Richter

发表

Cytochrome P450 3A4 and P‐glycoprotein Expression in Human Small Intestinal Enterocytes and Hepatocytes: A Comparative Analysis in Paired Tissue Specimens

Oliver Burk, Michel Eichelbaum, M. Fromm, 2004, Clinical pharmacology and therapeutics.

Shed human enterocytes as a tool for the study of expression and function of intestinal drug‐metabolizing enzymes and transporters

H. Glaeser, M. Fromm, M. Eichelbaum, 2002, Clinical pharmacology and therapeutics.

Magnesium Hydroxide/Aluminium Hydroxide‐Containing Antacid Does Not Affect the Pharmacokinetics of the Targeted Phosphodiesterase 4 Inhibitor Roflumilast

R. Hermann, O. Richter, G. Lahu, 2007, Journal of clinical pharmacology.

Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique

M. Fromm, M. Eichelbaum, A. Somogyi, 2001, Clinical pharmacology and therapeutics.

Induction of P‐glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction

Michael Zschiesche, Dieter Schrenk, Werner Siegmund, 2000, Clinical pharmacology and therapeutics.

Unexpected effect of verapamil on oral bioavailability of the β‐blocker talinolol in humans

W. Kirch, U. Schwarz, R. Oertel, 1999 .

Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N‐Oxide

R. Hermann, O. Richter, G. Lahu, 2008, Journal of clinical pharmacology.

Core Entrustable Professional Activities in Clinical Pharmacology: Pearls for Clinical Practice

A. Rostami-Hodjegan, H. Derendorf, R. Hermann, 2018, Journal of clinical pharmacology.

Digoxin, Flecainide, and Amiodarone Transfer Across the Placenta and the Effects of an Elevated Umbilical Venous Pressure on the Transfer Rate

T. Höller, H. Schlebusch, O. Richter, 2000, Therapeutic drug monitoring.

Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity

M. Ingelman-Sundberg, R. Hermann, O. Richter, 2006, Clinical pharmacology and therapeutics.

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.

H K Kroemer, M. Eichelbaum, H. Kroemer, 1999, The Journal of clinical investigation.

Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects

R. Hermann, K. Erb, B. Schug, 2007 .

Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide

R. Hermann, O. Richter, G. Lahu, 2007, Clinical pharmacokinetics.

In vitro interaction of codeine and diclofenac.

U. Hofmann, M. Eichelbaum, G. Mikus, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.

M. Fromm, M. Eichelbaum, T. Mettang, 2000, The Journal of pharmacology and experimental therapeutics.